Form 8-K - Current report:
SEC Accession No. 0001299933-11-003397
Filing Date
2011-11-22
Accepted
2011-11-21 18:25:22
Documents
2
Period of Report
2011-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_43575.htm 8-K 12062
2 EX-10.28 exhibit1.htm EX-10.28 89825
  Complete submission text file 0001299933-11-003397.txt   103040
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 111220058
SIC: 2834 Pharmaceutical Preparations